MSc/PGDiploma in Clinical Research and Regulatory Affairs MCR104 - BASICS OF PHARMACY, DRUG DISCOVERY AND DEVELOPMENT

Size: px
Start display at page:

Download "MSc/PGDiploma in Clinical Research and Regulatory Affairs MCR104 - BASICS OF PHARMACY, DRUG DISCOVERY AND DEVELOPMENT"

Transcription

1 PROGRAM SEMESTER SUBJECT BOOK ID MSc/PGDiploma in Clinical Research and Regulatory Affairs MCR - BASICS OF PHARMACY, DRUG DISCOVERY AND DEVELOPMENT B709 SESSION FALL 0 No Question/Answer key Marks Total Marks Q A Define packaging with respect to pharmaceuticals. List out the functions of packaging. Describe the different types of packaging in drug industry. ( Unit ; Section.,.. ) Defining packaging It is defined as the collection of different components which surround the pharmaceutical product from the time of production until its use. Packaging also refers to the process of design, evaluation, and production of packages. Packaging can be described as a coordinated system of preparing goods for transport, warehousing, logistics, sale, and end use. Listing the functions of packaging A] Containment: The containment of the product is the most fundamental function of packaging for medicinal products. This requires the packaging: not to leak, nor allow diffusion and permeation of the product to be strong enough to hold the contents when subjected to normal handling Not to be altered by the ingredients of the formulation in its final dosage form. B] Protection: The packaging must protect the product against all adverse external influences that may affect its quality or potency, such as: Light Moisture Oxygen Biological contamination Mechanical damage C] Stability Parameters: Protect the Product from Moisture and Gas. Light and Temperature Protection. Microbiological Integrity ph Stability Q A "primary", "secondary", tertiary, Unit-dose packaging and Device packaging Discuss briefly about "primary", "secondary", tertiary, Unit-dose packaging and Device packaging. Define DMF. List out the types of Drug Master Files. Explain the submissions to Drug Master Files. ( Unit 6 ; Section 6.6 )

2 Defining DMF A Drug Master File (DMF) is a submission to the Food and Drug Administration (FDA) that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs. A DMF is submitted solely at the discretion of the holder. The information contained in the DMF may be used to support an Investigational New Drug Application (IND), a New Drug Application (NDA), an Abbreviated New Drug Application (ANDA), another DMF, an Export Application, or amendments and supplements to any of these. Q A Types of DMFs There are five types of DMFs: ) Type I: Manufacturing site, facilities, operating procedures, and personnel. ) Type II: Drug substance, drug substance intermediate, and material used in their preparation, or drug product. ) Type III: packaging material. ) Type IV: Excipient, colorant, flavor, essence, or material used in their preparation. ) Type V: FDA accepted reference information. Submissions to Drug Master Files Each DMF submission should contain a transmittal letter, administrative information about the submission, and the specific information to be included in the DMF. The DMF must be in the English language. Whenever a submission contains information in another language, an accurate certified English translation must also be included. Each page of each copy of the DMF should be dated and consecutively numbered. An updated table of contents should be included with each submission. Define pharmacokinetics and pharmacodynamics. Briefly describe the different pharmacokinetic processes that determine the drug concentration in the body when medicines are prescribed. ( Unit ; Section.7 ) Defining pharmacokinetics and pharmacodynamics Defining Pharmacokinetics: Pharmacokinetics sometimes abbreviated as PK and it is the area related to pharmacology and biopharmaceutics, dedicated to the determination of the fate of substances administered externally to a living organism. In short, it deals with ADME (Absorption, Distribution, Metabolism and Elimination or Excretion) of the drug. Defining pharmacodynamics: Pharmacodynamics is sometimes abbreviated as "PD". It is the study of the biochemical and physiological effects of drugs and the mechanisms of drug action and the relationship between drug concentration and effect. It is often summarily stated that pharmacodynamics is the study of what a drug does to the body. Pharmacokinetic processes-adme Describing different pharmacokinetic processes-adme Pharmacokinetic processes that determine the drug concentration in the body Brief description of different pharmacokinetic processes that determine the drug concentration in the body when medicines are prescribed.

3 Q A Define personalized medicine. Explain the advantages and disadvantages of personalized medicine in respect to health care industry in future. ( Unit ; Section.,..,.. ) Definition of personalized medicine Personalized medicine is moving us closer to more precise, predictable and powerful medicine which is customized for the individual patient. Therefore matching patients to treatments by screening their genetic makeup is the goal of some drugs companies. Advantages of personalized medicine a) More powerful medicine b) Safer drugs c) More accurate drug dosages d) Screening for disease e) Better vaccines f) Economically viable personalized medicine Disadvantages of personalized medicine ) Not everybody welcomes personalized medicine with the same enthusiasm as doctors and those with an increased risk of inherited diseases. The idea of having their health records and, even worse, their genetic data stored in a central database scares many people in the First World, who already feel insufficiently protected against intrusions into their private lives and many ethicists and doctors agree, as the possibilities for abuse are numerous. ) Health insurers might increase premiums for people with a high number of risk factors. ) Employers might decide against applicants or even lay off workers if their genetic make-up indicates that they have a higher risk of developing job-related ailments. ) Life insurance companies might refuse to insure people who have a higher chance of stroke, heart failure or cancer. ) Physicians fear that storing health and genetic data might impede medical practice and biomedical research when patients refuse to disclose this information if they do not trust their physicians to use it in their best interest. Q A Define chromatography. Classify different chromatographic methods and explain. ( Unit ; Section.,.. ) Defining Chromatography Chromatography is a dynamic process in which a molecular mixture is separated depending upon the differential affinity of solutes between two immiscible phases (mobile and stationary phase). Mobile phase - mobile phase can be liquid, mixture of solutions or solvents or a pure gas or mixture of gases. Stationary phase - it is a fine bed of large surface area. It may be highly porous or finely divided solid or granular solid or it can also be a thin film of liquid supported on a suitable inert solid (support). Classification of chromatography By the physical state of the mobile phase and stationary phase By the method of contact between the mobile phase and stationary phase or By the chemical or physical mechanism responsible for separating the sample s constituents.

4 Different chromatographic techniques based on the classification Describe different chromatographic techniques based on the classification in details. A) Based on principle of separation i) Adsorption chromatography ii) Partition chromatography iii) Ion-exchange chromatography iv) Size-exclusion chromatography v) Electrophoretic separation B) Based on mode of separation ) Normal Phase Chromatography ) Reverse Phase Chromatography C) Based on mode of bringing together the stationary and mobile phase ) Column chromatography ) Paper chromatography ) Gel permeation chromatography ) Liquid chromatography (LC) ) Gas chromatography 6) High Performance Liquid Chromatography (HPLC) 7) Thin-Layer Chromatography (TLC) 8) High Performance Thin-Layer Chromatography (HPTLC) 8 Q 6 A 6 Discuss different criteria used in selecting the analytical methods. ( Unit ; Section.. ) Listing design criteria Listing different criteria which are used in selecting the analytical methods are: accuracy, precision, sensitivity, specificity, selectivity, robustness, ruggedness, scale of operation, analysis time, availability of equipment and unit cost of the analysis. Discussing each criteria i) Accuracy: It is a measure of how closely the result of an experiment agrees with the expected result. ii) Precision: When a sample is analyzed several times, the individual results are rarely the same. Instead, the results are randomly scattered. Precision is a measure of this variability. iii) Sensitivity: It is the change in signal per unit change in the amount of analyte. Sensitivity is often confused with a method s detection limit. iv) Selectivity: The extent to which the method can determine a particular analyte in a complex mixture without interference from other components in the mixture. v) Robustness: For a method to be useful, it must provide reliable results. vi) Ruggedness: Random variations in experimental conditions also introduce uncertainty. If a method s sensitivity is highly dependent on experimental conditions, such as temperature, acidity, or reaction time, then slight changes in those conditions may lead to significantly different results. A rugged method is relatively insensitive to changes in experimental conditions. vii) Instrumentation, time and cost: Analytical methods can be compared in terms of their need for equipment, the time required to complete an analysis, and the cost per sample.methods relying on instrumentation are equipment-intensive and may require significant operator training. The time needed to complete an analysis for a single sample is often fairly similar from method to method. The cost of an analysis is determined by many factors, 8

5 including the cost of necessary equipment and reagents, the cost of hiring analysts, and the number of samples that can be processed per hour. In general, methods relying on instruments cost more per sample than other methods. viii) Making the final choice: The best method is often dictated by the sample s properties.

CTD Dossier Preparation. Sr.Manager-Regulatory Affairs

CTD Dossier Preparation. Sr.Manager-Regulatory Affairs CTD Dossier Preparation K. Srikantha Reddy Sr.Manager-Regulatory Affairs Medreich Limited Srikanth.k@medreich.com CTD Dossier Preparation CTD (Common Technical Document) contains 5 modules Module 1 Module

More information

VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1)

VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1) INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY

More information

Annex 9 Guide to good storage practices for pharmaceuticals 1

Annex 9 Guide to good storage practices for pharmaceuticals 1 World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 9 Guide to good storage practices for pharmaceuticals 1 1. Introduction 125 2. Glossary 126 3. Personnel 128 4. Premises and facilities

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q2B Validation of Analytical Procedures: Methodology November 1996 ICH Guidance for Industry Q2B Validation of Analytical Procedures: Methodology Additional copies are available from:

More information

Pharmacology skills for drug discovery. Why is pharmacology important?

Pharmacology skills for drug discovery. Why is pharmacology important? skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th

More information

Validation and Calibration. Definitions and Terminology

Validation and Calibration. Definitions and Terminology Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an

More information

Introduction to pharmaceutical technology

Introduction to pharmaceutical technology Introduction to pharmaceutical technology Marie Wahlgren Chapter 1 What is the topics of today Introduction to the course Introduction to the project assignment How to choose a new drug formulation 1 Contacts

More information

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(2):892-898 World Health Organization s Guidelines for

More information

Importing pharmaceutical products to China

Importing pharmaceutical products to China Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval

More information

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aaps.org/forstudents How Do I Know If a Career in the Pharmaceutical Sciences is Right

More information

PRINCIPLES OF PHARMACOLOGY. MEDICAL ASSISTANT S ROLE History: Drug Legislation & Regulation. Education: indication, instructions, side effects

PRINCIPLES OF PHARMACOLOGY. MEDICAL ASSISTANT S ROLE History: Drug Legislation & Regulation. Education: indication, instructions, side effects PRINCIPLES OF PHARMACOLOGY Medical Assistants At the heart of health care MEDICAL ASSISTANT S ROLE History: prescription over the counter (OTC) alcohol (ETOH), recreational, smoking, herbal remedies Education:

More information

Pharmacy Technician Diploma (Part Time) - SC232

Pharmacy Technician Diploma (Part Time) - SC232 Pharmacy Technician Diploma (Part Time) - SC232 1. Special Note The Programme is designed to be a professional course, like the Diploma/BSc (Hons) Biomedical Sciences and the Diploma/BSc (Hons) Occupational

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

Air Sampling for Gases and Vapors. Patrick N. Breysse, PhD, CIH Peter S.J. Lees, PhD, CIH Johns Hopkins University

Air Sampling for Gases and Vapors. Patrick N. Breysse, PhD, CIH Peter S.J. Lees, PhD, CIH Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Nursing 113. Pharmacology Principles

Nursing 113. Pharmacology Principles Nursing 113 Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a. pharmacotherapeutics b. pharmacology c. pharmacodynamics

More information

Pharmaceutical Sciences

Pharmaceutical Sciences Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aapspharmaceutica.com/students How do I know if a career in the pharmaceutical sciences

More information

Pharmacy Technician Syllabus 14152

Pharmacy Technician Syllabus 14152 Pharmacy Technician Syllabus 14152 Dianne Rider 43745 180 th Street Hazel, SD 57242 Instructor Home Phone (605) 628-2103 Cell Phone (605) 881-3973 Email: dianne.rider@k12.sd.us Course Description Aim:

More information

ICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology. Step 5

ICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology. Step 5 European Medicines Agency June 1995 CPMP/ICH/381/95 ICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology Step 5 NOTE FOR GUIDANCE ON VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND

More information

2014 Annual Report on Inspections of Establishments

2014 Annual Report on Inspections of Establishments 2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered

More information

Drug Development Process

Drug Development Process Drug Development Process Original Arthur: Addie D. Anderson CRB Consulting Engineers, Inc. Overview Important milestones establishing our current system of regulations Step-by-step overview of the drug

More information

MINISTRY OF HIGHER EDUCATION UNIVERSITY OF HAIL COLLEGE OF PHARMACY

MINISTRY OF HIGHER EDUCATION UNIVERSITY OF HAIL COLLEGE OF PHARMACY MINISTRY OF HIGHER EDUCATION UNIVERSITY OF HAIL COLLEGE OF PHARMACY Academic Reference Standards of Pharm.-D Program College of Pharmacy-University of Hail May The Major shift in the health-care system

More information

Annex 7 Guidelines for the preparation of a contract research organization master file

Annex 7 Guidelines for the preparation of a contract research organization master file World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 7 Guidelines for the preparation of a contract research organization master file Background 1. General information 2. Quality

More information

Guidance for Industry

Guidance for Industry Guidance for Industry for the Submission of Chemistry, Manufacturing, and Controls Information for Synthetic Peptide Substances Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

Not All Clinical Trials Are Created Equal Understanding the Different Phases

Not All Clinical Trials Are Created Equal Understanding the Different Phases Not All Clinical Trials Are Created Equal Understanding the Different Phases This chapter will help you understand the differences between the various clinical trial phases and how these differences impact

More information

Guidance for Industry

Guidance for Industry 5 Guidance for Industry Drug Stability Guidelines (This version of the guidance replaces the version that was made available in December 1990. This guidance document has been revised to correct the contact

More information

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high

More information

Thomas Hinchliffe, Pharm.D. CDR, U.S. Public Health Service Special Assistant to the Director Office of Generic Drugs Food and Drug Administration

Thomas Hinchliffe, Pharm.D. CDR, U.S. Public Health Service Special Assistant to the Director Office of Generic Drugs Food and Drug Administration Thomas Hinchliffe, Pharm.D. CDR, U.S. Public Health Service Special Assistant to the Director Office of Generic Drugs Food and Drug Administration Disclaimer & Disclosure Views presented are those of the

More information

BIOTECHNOLOGY OPERATIONS

BIOTECHNOLOGY OPERATIONS BIOTECHNOLOGY OPERATIONS Principles and Practices Michael J. Roy TECHNISCHE INFORMATION SBIBLIOTHEK UNIVERSITATSBIBLIOTHEK HANNOVER CRC Press TaylorStFrancis Croup Boca Raton London New York CRC Press

More information

Complete Pharmacy Technician Certificate Program 230 clock hours

Complete Pharmacy Technician Certificate Program 230 clock hours Complete Pharmacy Technician Certificate Program 230 clock hours Course Description Our Pharmacy Technician Career Training Program will give the pharmacy technician the knowledge to achieve the competencies

More information

AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin)

AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin) AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin) Description AMBERLITE IRP64 [1] resin is an insoluble, weakly acidic, hydrogen form, cation exchange resin supplied as a dry,

More information

Design of Experiments for Analytical Method Development and Validation

Design of Experiments for Analytical Method Development and Validation Design of Experiments for Analytical Method Development and Validation Thomas A. Little Ph.D. 2/12/2014 President Thomas A. Little Consulting 12401 N Wildflower Lane Highland, UT 84003 1-925-285-1847 drlittle@dr-tom.com

More information

From the Text. Definitions. Definitions. Definitions. Definitions. RSPT 2217 Basic Concepts & Principles. RSPT 2217-01 Basic Concepts

From the Text. Definitions. Definitions. Definitions. Definitions. RSPT 2217 Basic Concepts & Principles. RSPT 2217-01 Basic Concepts RSPT 2217 & Principles Gardenhire Chapter 1; p. 1-10 From the Text Key Terms and page 2 Orphan Drugs Table 1-1; page 6 Abbreviations Table 1-2; page 8 Aerosolized Agents Table 1-3; page 9 Drug: Pharmacology:

More information

GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.

GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS. GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS October 2004 APVMA PO Box E240 KINGSTON 2604 AUSTRALIA http://www.apvma.gov.au

More information

CATEGORY Advertising. CATEGORY Biopharmaceutics. CATEGORY Biosimilarity

CATEGORY Advertising. CATEGORY Biopharmaceutics. CATEGORY Biosimilarity CATEGORY Advertising Guidance Agenda: New & Guidances CDER is Planning to Publish During Calendar Year 2016 (See the Good Guidance Practices (GGPs) regulation on this Web page or 21 CFR 10.115 for details

More information

BS in Pharmaceutical Science (BSPS) degree program University of Rhode Island

BS in Pharmaceutical Science (BSPS) degree program University of Rhode Island To prepare students for careers in the pharmaceutical, biotechnical, consumer product and health care industries. Types of work include laboratory, regulatory oversight, engineering, economics, marketing,

More information

GAO NEW DRUG DEVELOPMENT. Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts

GAO NEW DRUG DEVELOPMENT. Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts GAO United States Government Accountability Office Report to Congressional Requesters November 2006 NEW DRUG DEVELOPMENT Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering

More information

Goals & Objectives. Drug Development & the FDA Pharmacy 309. Outline. An History of Disasters. Be able to describe

Goals & Objectives. Drug Development & the FDA Pharmacy 309. Outline. An History of Disasters. Be able to describe Drug Development & the FDA Pharmacy 309 Tom Hazlet, Pharm.D., Dr.P.H. 616-2732 thazlet@u... Goals & Objectives Be able to describe the major regulatory events in the drug development process the concepts

More information

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 Quality by Design Approaches to Analytical Methods -- FDA Perspective Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 1 Outline What is Quality by Design (QbD) Role of Analytical

More information

The Clinical Trials Process an educated patient s guide

The Clinical Trials Process an educated patient s guide The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Major, Minor, and Telephone Amendments to Abbreviated New Drug Applications Comments and suggestions regarding this document should be submitted within 90 days of publication in the

More information

Masters Learning mode (Форма обучения)

Masters Learning mode (Форма обучения) Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)

More information

Graduate Program Objective #1 Course Objectives

Graduate Program Objective #1 Course Objectives 1 Graduate Program Objective #1: Integrate nursing science and theory, biophysical, psychosocial, ethical, analytical, and organizational science as the foundation for the highest level of nursing practice.

More information

BUSINESS, CONSUMER SERVICES, AND HOUSING AGENCY GOVERNOR EDMUND G. BROWN JR.

BUSINESS, CONSUMER SERVICES, AND HOUSING AGENCY GOVERNOR EDMUND G. BROWN JR. INSTRUCTIONS FOR APPLYING FOR A NURSE PRACTITIONER FURNISHING NUMBER Section 2836.3 of the Business and Professions Code requires that the Nurse Practitioner who wishes to furnish drugs and/or devices

More information

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC

More information

QbD Considerations for Analytical Methods - FDA Perspective

QbD Considerations for Analytical Methods - FDA Perspective QbD Considerations for Analytical Methods - FDA Perspective IFPAC Annual Meeting Baltimore, January 25, 2013 Sharmista Chatterjee, Ph.D. CMC Lead for QbD ONDQA/CDER/FDA Outline Role of analytics in drug

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

CTC Technology Readiness Levels

CTC Technology Readiness Levels CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.

More information

PHARMACOVIGILANCE GUIDELINES

PHARMACOVIGILANCE GUIDELINES PHARMACOVIGILANCE GUIDELINES What is Pharmacovigilance? Pharmacovigilance is defined as the science and activities concerned with the detection, assessment, understanding and prevention of adverse reactions

More information

Regulatory Strategy for Drug-Device Combinations By John Worroll

Regulatory Strategy for Drug-Device Combinations By John Worroll THE MEDICAL DEVICE CONSULTING, AUDITING & TRAINING EXPERTS Regulatory Strategy for Drug-Device Combinations By John Worroll Introduction Drug-device combinations have always been a challenge to the regulatory

More information

DMPK: Experimentation & Data

DMPK: Experimentation & Data DMPK: Experimentation & Data Interpretation Mingshe Zhu, Mike S. Lee, Naidong Weng, and Mark Hayward Prerequisite: Entry-level scientists with hands on experience in LC/MS as well as advanced students

More information

Separation of Amino Acids by Paper Chromatography

Separation of Amino Acids by Paper Chromatography Separation of Amino Acids by Paper Chromatography Chromatography is a common technique for separating chemical substances. The prefix chroma, which suggests color, comes from the fact that some of the

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Providing Regulatory Submissions in Electronic Format Drug Establishment Registration and Drug Listing U.S. Department of Health and Human Services Food and Drug Administration Office

More information

Title 22: HEALTH AND WELFARE

Title 22: HEALTH AND WELFARE Title 22: HEALTH AND WELFARE Chapter 157-A: HEALTH AND ENVIRONMENTAL TESTING LABORATORY HEADING: PL 1991, c. 499, 2 (new) Table of Contents Subtitle 2. HEALTH... Part 2. STATE AND LOCAL HEALTH AGENCIES...

More information

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Charlesworth Rae, BS, PharmD, JD Investigational Drug Pharmacist July 2012 1 Outline of Presentation I. Introduction

More information

School of Pharmacy TEMPLE UNIVERSITY

School of Pharmacy TEMPLE UNIVERSITY School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme

More information

Overview of Drug Development: the Regulatory Process

Overview of Drug Development: the Regulatory Process Overview of Drug Development: the Regulatory Process Roger D. Nolan, PhD Director, Project Operations Calvert Research Institute November, 2006 Adapted from course taught by Cato Research Background: Roger

More information

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof; DIRECTIVE 65/65/EEC Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (OJ L No 22 of

More information

PL 17871/0208 UKPAR TABLE OF CONTENTS

PL 17871/0208 UKPAR TABLE OF CONTENTS Fultium-D 3 3,200 IU Capsules PL 17871/0208 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 4 Steps taken for assessment Page 11 Summary of Product Characteristics Page 12 Patient

More information

Implementing New USP Chapters for Analytical Method Validation

Implementing New USP Chapters for Analytical Method Validation Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: Ludwig_Huber@labcompliance.com Today s Agenda Handling Method Changes vs. Adjustments

More information

September 19, 1984 FOOD PRODUCTION AND DIRECTION GÉNÉRALE, SECTION INSPECTION BRANCH PRODUCTION ET INSPECTION PESTICIDES DES ALIMENTS TRADE MEMORANDUM

September 19, 1984 FOOD PRODUCTION AND DIRECTION GÉNÉRALE, SECTION INSPECTION BRANCH PRODUCTION ET INSPECTION PESTICIDES DES ALIMENTS TRADE MEMORANDUM Agriculture Canada September 19, 1984 T-1-245 FOOD PRODUCTION AND DIRECTION GÉNÉRALE, SECTION INSPECTION BRANCH PRODUCTION ET INSPECTION PESTICIDES DES ALIMENTS TRADE MEMORANDUM RE: Guidelines for Developing

More information

Guidance for Industry Time and Extent Applications for Nonprescription Drug Products

Guidance for Industry Time and Extent Applications for Nonprescription Drug Products Guidance for Industry Time and Extent Applications for Nonprescription Drug Products U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT Guideline Title Specifications and Control Tests on the Finished Product Legislative basis Directive 75/318/EEC as amended Date of first adoption

More information

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services

More information

Guidance for Industry. Monoclonal Antibodies Used as Reagents in Drug Manufacturing

Guidance for Industry. Monoclonal Antibodies Used as Reagents in Drug Manufacturing Guidance for Industry Monoclonal Antibodies Used as Reagents in Drug Manufacturing U.S. Department of Health and Human Services Food and Drug Administration enter for Drug Evaluation and Research (DER)

More information

REGULATIONS FOR THE DEGREE OF BACHELOR OF PHARMACY IN CHINESE MEDICINE [PART-TIME] (BPharm[ChinMed])

REGULATIONS FOR THE DEGREE OF BACHELOR OF PHARMACY IN CHINESE MEDICINE [PART-TIME] (BPharm[ChinMed]) REGULATIONS FOR THE DEGREE OF BACHELOR OF PHARMACY IN CHINESE MEDICINE [PART-TIME] (BPharm[ChinMed]) These regulations apply to students admitted to the first year of study in and after the academic year

More information

Technology Transfer of CMC Activities for MAb Manufacturing. 2010 ge healthcare (www.gelifesciences.com)

Technology Transfer of CMC Activities for MAb Manufacturing. 2010 ge healthcare (www.gelifesciences.com) M a n u f a c t u r i n g OPERATIONS Technology Transfer of CMC Activities for MAb Manufacturing by Patricia Seymour, Susan Dana Jones, Howard L. Levine With combined 2009 revenues estimated to be over

More information

Glossary of Clinical Trial Terms

Glossary of Clinical Trial Terms Glossary of Clinical Trial Terms ADVERSE REACTION: (Adverse Event): Also known as side effects, adverse reactions include any undesired actions or effects of the experimental drug or treatment. Experimental

More information

Contents. Contributors. 1 Quality control and regulation 1 C.J. MOORES

Contents. Contributors. 1 Quality control and regulation 1 C.J. MOORES Contents Contributors Preface xiii xiv 1 Quality control and regulation 1 C.J. MOORES 1.1 Introduction 1 1.2 The quality of medicines 2 1.2.1 The meaning of quality 2 1.2.2 Medicines are special 3 1.2.3

More information

IMPORTANCE OF THE ENFORCEMENT OF THE LAW AND EU DIRECTIVES CONCERNING TRANSLATION OF PHARMACEUTICALS LEAFLETS

IMPORTANCE OF THE ENFORCEMENT OF THE LAW AND EU DIRECTIVES CONCERNING TRANSLATION OF PHARMACEUTICALS LEAFLETS IMPORTANCE OF THE ENFORCEMENT OF THE LAW AND EU DIRECTIVES CONCERNING TRANSLATION OF PHARMACEUTICALS LEAFLETS Qendro Gentiana Planetary University, Faculty of Medical Sciences, Department of Pharmacy,

More information

SAMPLE DRUG AND ALCOHOL POLICY

SAMPLE DRUG AND ALCOHOL POLICY SAMPLE DRUG AND ALCOHOL POLICY (MISSISSIPPI) DRUG AND ALCOHOL POLICY DISCLAIMER WARNING!!! The attached Drug and Alcohol Policy is being furnished to you as a courtesy. Stonetrust Management Services highly

More information

Fractional Distillation and Gas Chromatography

Fractional Distillation and Gas Chromatography Fractional Distillation and Gas Chromatography Background Distillation The previous lab used distillation to separate a mixture of hexane and toluene based on a difference in boiling points. Hexane boils

More information

February 2006 Procedural

February 2006 Procedural Guidance for Industry Reports on the Status of Postmarketing Study Commitments Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997 U.S. Department of Health and

More information

Research on Research: Learning about Phase 1 Trials

Research on Research: Learning about Phase 1 Trials CLINICAL CASE STUDY SERIES Research on Research: Learning about Phase 1 Trials Phases of clinical trial investigation are described in some detail in the Code of Federal Regulations. Phase 1 is described

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products For questions on the content of the guidance,

More information

The 505(b)(2) Drug Development Pathway:

The 505(b)(2) Drug Development Pathway: The 505(b)(2) Drug Development Pathway: When and How to Take Advantage of a Unique American Regulatory Pathway By Mukesh Kumar, PhD, RAC and Hemant Jethwani, MS The 505(b)(2) regulation offers a less expensive

More information

UW School of Dentistry Comprehensive Medication Policy

UW School of Dentistry Comprehensive Medication Policy UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides

More information

Editorial Calendar 2014

Editorial Calendar 2014 Editorial Calendar 2014 IPI is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.ipimediaworld.com website for Peer Review Protocol and Authors Guidelines. The topics and subjects

More information

Overview of Pre-Approval Inspections

Overview of Pre-Approval Inspections Overview of Pre-Approval Inspections Presented by: Kelli F. Dobilas NWJ-DO Pre-Approval Manager Pre-Approval Drug Inspections What are Pre-Approval Inspections? One of the last reviews of the drug approval

More information

Combination Products Regulation in the United States

Combination Products Regulation in the United States Combination Products Regulation in the United States Presenter: Scott Sardeson RAC US/EU 3M Health Care St. Paul, MN USA 1 Presentation Outline Combination products Definitions and Regulations Jurisdiction

More information

Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen. -Senior Manager Biotechnology-

Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen. -Senior Manager Biotechnology- Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen -Senior Manager Biotechnology- 2005 by West Pharmaceutical Services, Inc., Lionville, PA All rights reserved.

More information

New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products

New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug

More information

An Advanced Base Deactivated Capillary Column for analysis of Volatile amines Ammonia and Alcohols.

An Advanced Base Deactivated Capillary Column for analysis of Volatile amines Ammonia and Alcohols. An Advanced Base Deactivated Capillary Column for analysis of Volatile amines Ammonia and Alcohols. Jaap de Zeeuw, Ron Stricek and Gary Stidsen Restek Corp Bellefonte, USA To analyze basic compounds at

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Scientific Considerations in Demonstrating Biosimilarity to a Reference Product DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Submitting Debarment Certification Statements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document

More information

ANALYTICAL METHODS INTERNATIONAL QUALITY SYSTEMS

ANALYTICAL METHODS INTERNATIONAL QUALITY SYSTEMS VALIDATION OF ANALYTICAL METHODS 1 GERT BEUVING INTERNATIONAL PHARMACEUTICAL OPERATIONS TASKS: - Internal auditing - Auditing of suppliers and contract manufacturers - Preparing for and guiding of external

More information

Doctor of Pharmacy Degree Requirements

Doctor of Pharmacy Degree Requirements College of Pharmacy 2010-2011 1 Doctor of Pharmacy Degree Requirements Following admission to the professional division, the entry-level Pharm.D. program students will complete a bachelor of science in

More information

Analytical Methods for Cleaning Validation

Analytical Methods for Cleaning Validation Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3 (6): 232-239 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Course Curriculum for Master Degree in Clinical Pharmacy

Course Curriculum for Master Degree in Clinical Pharmacy Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon

More information

INSTITUTE OF CLINICAL PHARMACY

INSTITUTE OF CLINICAL PHARMACY INSTITUTE OF CLINICAL PHARMACY TEL: 886-6-353535 ext. 568 FAX: 886-6-37349 E-MAIL:em75500@email.ncku.edu.tw BRIEF INTRODUCTION Many departments and institutes have been established since 984, when National

More information

(1) Cancer drug means a prescription drug that is used to treat cancer or the side effects of cancer.

(1) Cancer drug means a prescription drug that is used to treat cancer or the side effects of cancer. DEPARTMENT OF PUBLIC HEALTH AND ENVIRONMENT Health Promotion and Disease Prevention Services CANCER DRUG REPOSITORY PROGRAM 6 CCR 1015-10 [Editor s Notes follow the text of the rules at the end of this

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Analytical Procedures and Methods Validation Chemistry, Manufacturing, and Controls Documentation DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

More information

RULE. The Administration of Medication in Louisiana Public Schools

RULE. The Administration of Medication in Louisiana Public Schools RULE The Administration of Medication in Louisiana Public Schools Developed in 1994 by The Louisiana State Board of Elementary and Secondary Education and The Louisiana State Board of Nursing Amendments

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP

Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP Document issued on: June 2004 U.S. Department of Health and Human Services Food and Drug Administration

More information

RESOLUTION-RDC Nr- 48, OF OCTOBER 6, 2009

RESOLUTION-RDC Nr- 48, OF OCTOBER 6, 2009 RESOLUTION-RDC Nr- 48, OF OCTOBER 6, 2009 This resolution provides for the alteration, inclusion, suspension, reactivation and cancellation after registration of medications and sets forth other provisions.

More information

SIMULTANEOUS DETERMINATION OF TELMISARTAN AND HYDROCHLOROTHIAZIDE IN TABLET DOSAGE FORM USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

SIMULTANEOUS DETERMINATION OF TELMISARTAN AND HYDROCHLOROTHIAZIDE IN TABLET DOSAGE FORM USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY CHAPTER 5 SIMULTANEOUS DETERMINATION OF TELMISARTAN AND HYDROCHLOROTHIAZIDE IN TABLET DOSAGE FORM USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY CHAPTER 5 Simultaneous determination of Telmisartan

More information

CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)

CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist

More information

Revision of The Dissolution Procedure: Development and Validation 1092

Revision of The Dissolution Procedure: Development and Validation 1092 Page 1 of 5 STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts Revision of The Dissolution Procedure: Development and Validation

More information

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs. 15 January 2007 GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.) TABLE OF CONTENTS 1 INTRODUCTION... 2 2

More information